'Miracle' obesity pill looks less miraculous
When Sanofi-Aventis SA reported data on a new obesity pill at a medical conference in March 2004, it generated instant buzz.
Read the rest of this entry ... (218 words left)
Acomplia (rimonabant) has not yet become a licensed product for smoking cessation in the UK. Whilst during clinical studies the drug clearly demonstrated a reduced craving for nicotine in patients the drug has only at the moment been approved as an obesity treatment. As this is a prescription medication we strongly advise that you seek to have a face-to-face consultation with your doctor in the first instance. This information should not be considered as a replacement to a doctor’s treatment.
